🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Mammography

Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer NCT06220214EARLY Phase 11 site📍 Stony Brook Alison Stopeck · Tests: CEDM, CEDBT, Omnipaque 350mgI/mL Solution for Injection Non-inferiority Study of Contrast-enhanced Digital Mammography (CEDM) vs Magnetic Resonance Imaging (MRI) in Terms of Diagnostic Accuracy in Patients Undergoing Preoperative Staging of Established Invasive Breast Cancer NCT07071272NA1 site📍 Verona Azienda Ospedaliera Universitaria Integrata Verona · Tests: breast-MRI and CEM Study on Female Patients' Mammographic Texture Features NCT06469606NA1 site📍 Tampere Tampere University Hospital · Tests: AI tool Women Informed to Screen Depending on Measures of Risk (Wisdom Study) NCT02620852NA11 sites📍 Birmingham📍 Irvine📍 Los Angeles University of California, San Francisco · Tests: Complete a health questionnaire, Provide a saliva sample for genetic testing, Screening advice based on a comprehensive… Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics NCT05056818n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Electronic Health Record Review Active Mammography and Counseling NCT07238088NA1 site📍 San Juan University of Puerto Rico Comprehensive Cancer Center · Tests: Individual Education, Community Navigation, Healthcare Providers Educational Intervention Artificial Intelligence in Mammography Screening in Norway NCT06032390NA1 site📍 Oslo Norwegian Institute of Public Health · Tests: AI assisted mammography screening interpretation, Standard mammography screening interpretation Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources (EMPOWER) in Underserved Populations Study NCT07029490NA1 site📍 Salt Lake City University of Utah · Tests: Chatbot Acquisition and Clinical Image Evaluation of Fujifilm's High Resolution (HR) Digital Breast Tomosynthesis (DBT) Images. NCT07471750NA1 site📍 Salt Lake City Fujifilm Medical Systems USA, Inc. · Tests: DBT HR mode image acquisition Breast Artery Calcification (BAC) and Female Cardiovascular Disease NCT07809932n/a1 site📍 Manhasset Northwell Health · Tests: Cardiac CT Scan, Bloodwork Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts NCT05625659NA13 sites📍 Birmingham📍 Boca Raton📍 The Villages American College of Radiology · Tests: Dual-Energy Contrast-Enhanced Spectral Mammography (CESM) Community-led Navigation to Address Disparities in Mammography Among Native American Women NCT06957535NA1 site📍 Chinle Johns Hopkins Bloomberg School of Public Health · Tests: Navigation, TEAM Supplemental Screening for Women With Extremely Dense Breast Tissue: the DENSE-2 Trial NCT06636370NA1 site📍 Utrecht C.H. van Gils · Tests: Contrast-enhanced mammography (CEM), Abbreviated MRI (AB-MRI) Positron Emission Mammography and Liquid Biopsy in Women With High-risk Breast Screenings NCT06268405NA1 site📍 Toronto University Health Network, Toronto · Tests: Liquid Biopsy, Positron Emission Mammography (PEM) Contrast Enhancement Mammography vs MRI for the Surveillance of Women at High Risk of Breast Cancer: Con-trust Randomized Controlled Trial NCT06629896NA1 site📍 Reggio Emilia Azienda USL Reggio Emilia - IRCCS · Tests: Contrast Enhancement Mammography, magnetic resonance imaging (MRI) and digital mammography (DM) Opportunistic Breast Cancer Screening Using Non-Contrast Chest CT NCT07557654n/a1 site📍 Shanghai Fudan University Breast Density Impact on Mammographic Screening for Breast Cancer Diagnosis NCT07415499n/a1 site📍 Verduno Azienda Sanitaria Locale CN2 Alba-Bra · Tests: No intervention is administered. A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients NCT06934239Phase 46 sites📍 Los Angeles📍 San Diego📍 Miami Jonsson Comprehensive Cancer Center · Tests: Artificial intelligence (AI) decision-support tool Contrast-enhanced Spectral Mammography (CESM) Early Quantitative Evaluation of Tumoral Response and Pathologic Complete Response Prediction for Localized Breast Cancer Treated by Neoadjuvant Chemotherapy NCT06299202NA1 site📍 Lyon Hospices Civils de Lyon · Tests: Diagnostic test Optimal Mammography View Sequencing in Women With a History of Breast Cancer Undergoing Surveillance Mammography NCT07443579NA1 site📍 Beaumont Royal College of Surgeons, Ireland · Tests: Mammography View Sequencing Testing a Mammography Decision Intervention in a Rural Setting NCT06522568NA3 sites📍 Keene📍 New London📍 Newport Dartmouth-Hitchcock Medical Center · Tests: MyMammogram, Provider communication Individualizing Approaches to Surveillance Mammography in Older Breast Cancer Survivors - The I-MAMMO Study NCT07123649Phase 21 site📍 Boston Dana-Farber Cancer Institute · Tests: Shared Decision-Making Toolkit B.Brilliant Revelation Comparision Study NCT07067788n/a1 site📍 Philadelphia University of Pennsylvania · Tests: Breast Imaging Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study NCT03408353n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Biospecimen Collection, Mammography, Questionnaire Administration Radiological Prediction of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer NCT06879704NA1 site📍 Rouen Centre Henri Becquerel · Tests: Imaging assessment ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health NCT07505797n/a2 sites📍 Sacramento📍 Cypress iSono Health, Inc. · Tests: ATUSA 3D Automated Breast Ultrasound System A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection NCT05300464NA4 sites📍 Genova📍 Foligno📍 Trieste Umbria Bioengineering Technologies · Tests: Clinical investigation medical device class IIa marked CE Individuals on Hormone Therapy Breast Cancer Screening Pilot NCT06383026n/a1 site📍 Milwaukee Medical College of Wisconsin · Tests: Breast Cancer Screening, Survey/Interview, Focus Group The C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Women With Dense Breasts NCT05667532NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Contrast Enhanced Mammography What is the Best Interval to Screen Women 45-49 and 70-74 for Breast Cancer? NCT04590560NA4 sites📍 Meldola (FC)📍 Florence📍 Forlì Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IR… · Tests: screening for breast cancer with tomosynthesis and synthetic 2D mammography performed at different interval compared to…
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy